Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

CBOE vs CME

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CBOE
Cboe Global Markets, Inc.

Financial - Data & Stock Exchanges

Financial ServicesAMEX • US
Market Cap$36.03B
5Y Perf.+223.1%
CME
CME Group Inc.

Financial - Data & Stock Exchanges

Financial ServicesNASDAQ • US
Market Cap$104.06B
5Y Perf.+57.1%

CBOE vs CME — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CBOE logoCBOE
CME logoCME
IndustryFinancial - Data & Stock ExchangesFinancial - Data & Stock Exchanges
Market Cap$36.03B$104.06B
Revenue (TTM)$4.71B$6.52B
Net Income (TTM)$1.10B$4.24B
Gross Margin48.9%86.1%
Operating Margin32.1%64.9%
Forward P/E27.4x23.5x
Total Debt$1.68B$3.76B
Cash & Equiv.$2.22B$4.42B

CBOE vs CMELong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CBOE
CME
StockMay 20May 26Return
Cboe Global Markets… (CBOE)100323.1+223.1%
CME Group Inc. (CME)100157.1+57.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: CBOE vs CME

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CBOE leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. CME Group Inc. is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
CBOE
Cboe Global Markets, Inc.
The Banking Pick

CBOE carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 15.1%, EPS growth 44.5%
  • 476.8% 10Y total return vs CME's 289.3%
  • PEG 1.40 vs CME's 1.71
Best for: growth exposure and long-term compounding
CME
CME Group Inc.
The Banking Pick

CME is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • Dividend streak 6 yrs, beta -0.30, yield 3.8%
  • Lower volatility, beta -0.30, Low D/E 13.1%, current ratio 92.97x
  • Beta -0.30, yield 3.8%, current ratio 92.97x
Best for: income & stability and sleep-well-at-night
See the full category breakdown
CategoryWinnerWhy
GrowthCBOE logoCBOE15.1% NII/revenue growth vs CME's 6.4%
ValueCME logoCMELower P/E (23.5x vs 27.4x)
Quality / MarginsCBOE logoCBOEEfficiency ratio 0.2% vs CME's 0.2% (lower = leaner)
Stability / SafetyCME logoCMELower D/E ratio (13.1% vs 32.8%)
DividendsCME logoCME3.8% yield, 6-year raise streak, vs CBOE's 0.8%
Momentum (1Y)CBOE logoCBOE+49.7% vs CME's +5.5%
Efficiency (ROA)CBOE logoCBOEEfficiency ratio 0.2% vs CME's 0.2%

CBOE vs CME — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CBOECboe Global Markets, Inc.
FY 2025
Transaction And Clearing Fees
76.3%$3.6B
Access And Capacity Fees
8.7%$409M
Market Data Fees
6.9%$327M
Regulatory Fees
6.1%$285M
Other Revenue
2.0%$96M
CMECME Group Inc.
FY 2025
clearing and transaction fees
81.0%$5.3B
MarketData
12.3%$803M
OtherRevenue
6.7%$436M

CBOE vs CME — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLCBOELAGGINGCME

Income & Cash Flow (Last 12 Months)

CME leads this category, winning 4 of 5 comparable metrics.

CME and CBOE operate at a comparable scale, with $6.5B and $4.7B in trailing revenue. CME is the more profitable business, keeping 62.0% of every revenue dollar as net income compared to CBOE's 23.3%.

MetricCBOE logoCBOECboe Global Marke…CME logoCMECME Group Inc.
RevenueTrailing 12 months$4.7B$6.5B
EBITDAEarnings before interest/tax$1.6B$4.7B
Net IncomeAfter-tax profit$1.1B$4.2B
Free Cash FlowCash after capex$1.2B$4.4B
Gross MarginGross profit ÷ Revenue+48.9%+86.1%
Operating MarginEBIT ÷ Revenue+32.1%+64.9%
Net MarginNet income ÷ Revenue+23.3%+62.0%
FCF MarginFCF ÷ Revenue+24.5%+64.3%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year+59.7%+21.4%
CME leads this category, winning 4 of 5 comparable metrics.

Valuation Metrics

CME leads this category, winning 4 of 7 comparable metrics.

At 25.7x trailing earnings, CME trades at a 22% valuation discount to CBOE's 33.0x P/E. Adjusting for growth (PEG ratio), CBOE offers better value at 1.69x vs CME's 1.87x — a lower PEG means you pay less per unit of expected earnings growth.

MetricCBOE logoCBOECboe Global Marke…CME logoCMECME Group Inc.
Market CapShares × price$36.0B$104.1B
Enterprise ValueMkt cap + debt − cash$35.5B$103.4B
Trailing P/EPrice ÷ TTM EPS33.01x25.70x
Forward P/EPrice ÷ next-FY EPS est.27.43x23.49x
PEG RatioP/E ÷ EPS growth rate1.69x1.87x
EV / EBITDAEnterprise value multiple21.69x22.95x
Price / SalesMarket cap ÷ Revenue7.64x15.96x
Price / BookPrice ÷ Book value/share7.04x3.60x
Price / FCFMarket cap ÷ FCF31.25x24.81x
CME leads this category, winning 4 of 7 comparable metrics.

Profitability & Efficiency

CBOE leads this category, winning 6 of 9 comparable metrics.

CBOE delivers a 23.0% return on equity — every $100 of shareholder capital generates $23 in annual profit, vs $15 for CME. CME carries lower financial leverage with a 0.13x debt-to-equity ratio, signaling a more conservative balance sheet compared to CBOE's 0.33x. On the Piotroski fundamental quality scale (0–9), CBOE scores 7/9 vs CME's 5/9, reflecting strong financial health.

MetricCBOE logoCBOECboe Global Marke…CME logoCMECME Group Inc.
ROE (TTM)Return on equity+23.0%+15.3%
ROA (TTM)Return on assets+12.2%+2.2%
ROICReturn on invested capital+17.9%+10.2%
ROCEReturn on capital employed+22.7%+3.6%
Piotroski ScoreFundamental quality 0–975
Debt / EquityFinancial leverage0.33x0.13x
Net DebtTotal debt minus cash-$532M-$666M
Cash & Equiv.Liquid assets$2.2B$4.4B
Total DebtShort + long-term debt$1.7B$3.8B
Interest CoverageEBIT ÷ Interest expense40.58x41.55x
CBOE leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

CBOE leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in CBOE five years ago would be worth $32,397 today (with dividends reinvested), compared to $16,437 for CME. Over the past 12 months, CBOE leads with a +49.7% total return vs CME's +5.5%. The 3-year compound annual growth rate (CAGR) favors CBOE at 37.0% vs CME's 19.8% — a key indicator of consistent wealth creation.

MetricCBOE logoCBOECboe Global Marke…CME logoCMECME Group Inc.
YTD ReturnYear-to-date+38.9%+9.1%
1-Year ReturnPast 12 months+49.7%+5.5%
3-Year ReturnCumulative with dividends+157.3%+71.9%
5-Year ReturnCumulative with dividends+224.0%+64.4%
10-Year ReturnCumulative with dividends+476.8%+289.3%
CAGR (3Y)Annualised 3-year return+37.0%+19.8%
CBOE leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CBOE and CME each lead in 1 of 2 comparable metrics.

CME is the less volatile stock with a -0.30 beta — it tends to amplify market swings less than CBOE's -0.27 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CBOE currently trades 99.3% from its 52-week high vs CME's 87.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCBOE logoCBOECboe Global Marke…CME logoCMECME Group Inc.
Beta (5Y)Sensitivity to S&P 500-0.27x-0.30x
52-Week HighHighest price in past year$346.48$329.16
52-Week LowLowest price in past year$212.75$257.17
% of 52W HighCurrent price vs 52-week peak+99.3%+87.1%
RSI (14)Momentum oscillator 0–10073.646.0
Avg Volume (50D)Average daily shares traded868K2.2M
Evenly matched — CBOE and CME each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — CBOE and CME each lead in 1 of 2 comparable metrics.

Wall Street rates CBOE as "Hold" and CME as "Hold". Consensus price targets imply 11.7% upside for CME (target: $320) vs -13.9% for CBOE (target: $296). For income investors, CME offers the higher dividend yield at 3.81% vs CBOE's 0.79%.

MetricCBOE logoCBOECboe Global Marke…CME logoCMECME Group Inc.
Analyst RatingConsensus buy/hold/sellHoldHold
Price TargetConsensus 12-month target$296.00$320.25
# AnalystsCovering analysts3135
Dividend YieldAnnual dividend ÷ price+0.8%+3.8%
Dividend StreakConsecutive years of raises106
Dividend / ShareAnnual DPS$2.71$10.92
Buyback YieldShare repurchases ÷ mkt cap+0.3%+0.3%
Evenly matched — CBOE and CME each lead in 1 of 2 comparable metrics.
Key Takeaway

CME leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). CBOE leads in 2 (Profitability & Efficiency, Total Returns). 2 tied.

Best OverallCboe Global Markets, Inc. (CBOE)Leads 2 of 6 categories
Loading custom metrics...

CBOE vs CME: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is CBOE or CME a better buy right now?

For growth investors, Cboe Global Markets, Inc.

(CBOE) is the stronger pick with 15. 1% revenue growth year-over-year, versus 6. 4% for CME Group Inc. (CME). CME Group Inc. (CME) offers the better valuation at 25. 7x trailing P/E (23. 5x forward), making it the more compelling value choice. Analysts rate Cboe Global Markets, Inc. (CBOE) a "Hold" — based on 31 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CBOE or CME?

On trailing P/E, CME Group Inc.

(CME) is the cheapest at 25. 7x versus Cboe Global Markets, Inc. at 33. 0x. On forward P/E, CME Group Inc. is actually cheaper at 23. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Cboe Global Markets, Inc. wins at 1. 40x versus CME Group Inc. 's 1. 71x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — CBOE or CME?

Over the past 5 years, Cboe Global Markets, Inc.

(CBOE) delivered a total return of +224. 0%, compared to +64. 4% for CME Group Inc. (CME). Over 10 years, the gap is even starker: CBOE returned +476. 8% versus CME's +289. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CBOE or CME?

By beta (market sensitivity over 5 years), CME Group Inc.

(CME) is the lower-risk stock at -0. 30β versus Cboe Global Markets, Inc. 's -0. 27β — meaning CBOE is approximately -11% more volatile than CME relative to the S&P 500. On balance sheet safety, CME Group Inc. (CME) carries a lower debt/equity ratio of 13% versus 33% for Cboe Global Markets, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — CBOE or CME?

By revenue growth (latest reported year), Cboe Global Markets, Inc.

(CBOE) is pulling ahead at 15. 1% versus 6. 4% for CME Group Inc. (CME). On earnings-per-share growth, the picture is similar: Cboe Global Markets, Inc. grew EPS 44. 5% year-over-year, compared to 15. 4% for CME Group Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CBOE or CME?

CME Group Inc.

(CME) is the more profitable company, earning 62. 0% net margin versus 23. 3% for Cboe Global Markets, Inc. — meaning it keeps 62. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CME leads at 64. 9% versus 32. 1% for CBOE. At the gross margin level — before operating expenses — CME leads at 86. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CBOE or CME more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Cboe Global Markets, Inc. (CBOE) is the more undervalued stock at a PEG of 1. 40x versus CME Group Inc. 's 1. 71x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, CME Group Inc. (CME) trades at 23. 5x forward P/E versus 27. 4x for Cboe Global Markets, Inc. — 3. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CME: 11. 7% to $320. 25.

08

Which pays a better dividend — CBOE or CME?

All stocks in this comparison pay dividends.

CME Group Inc. (CME) offers the highest yield at 3. 8%, versus 0. 8% for Cboe Global Markets, Inc. (CBOE).

09

Is CBOE or CME better for a retirement portfolio?

For long-horizon retirement investors, Cboe Global Markets, Inc.

(CBOE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 27), 0. 8% yield, +476. 8% 10Y return). Both have compounded well over 10 years (CBOE: +476. 8%, CME: +289. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CBOE and CME?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: CBOE is a mid-cap high-growth stock; CME is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

CBOE

High-Growth Quality Leader

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 7%
  • Net Margin > 14%
Run This Screen
Stocks Like

CME

Dividend Mega-Cap Quality

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 37%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CBOE and CME on the metrics below

Revenue Growth>
%
(CBOE: 15.1% · CME: 6.4%)
Net Margin>
%
(CBOE: 23.3% · CME: 62.0%)
P/E Ratio<
x
(CBOE: 33.0x · CME: 25.7x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.